The Protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion

Neurobiology of Disease

Volumn 8, Issue 2, 2001, Pages 266-278

  Gutmann, David H ^a   Hirbe, Angela C ^a   Huang, Zhi Yong ^a   Haipek, Carrie A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLYCOPROTEIN; MERLIN; PROTEIN DAL 1; SPECTRIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CYTOSKELETON; FEVER; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MENINGIOMA; NEURILEMOMA; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

EID: 0035029796     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2000.0376     Document Type: Article

References (43)

1. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas
2. The merlin tumor suppressor localizes preferentially in membrane ruffles
3. Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins
4. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas
5. Defects in neurofibromatosis 2 protein function can arise at multiple levels
6. Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations
7. Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading
8. Loss of DAL-1, a Protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas
9. Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2)
10. Ezrin regulates cell-cell and cellmatrix adhesion, a possible role with E-cadherin-catenin
11. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells
12. Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas, and meningiomas
13. Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer
14. Cloning and sequencing of porcine moesin and radixin cDNA and identification of highly conserved domains
15. Reduced expression of schwannomin/merlin in human sporadic meningiomas
16. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors
17. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas
18. NHE-RF, a regulatory cofactor for Na+-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins
19. Merlin, the neurofibromatosis type 2 gene product, and b1 integrin associate in isolated and differentiating Schwann cells
20. Molecular and functional characterization of Protein 4.1B, a novel member of the Protein 4.1 family with high level, focal expression in brain
21. Ruffling membrane, stress fiber, cell spreading, and proliferation abnormalities in human schwannoma cells
22. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: A correlative immunohistochemistry study of 175 cases
23. Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family
24. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
25. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas
26. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas
27. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton
28. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas
29. Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells
30. Neurofibromatosis 2 tumour suppressor schwannomin interacts with netaII-spectrin
31. The neurofibromatosis 2 tumor suppressor protein interacts with hepatocyte growth factor-regulated tyrosine kinase substrate
32. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer
33. Interdomain binding mediates tumor growth suppression by the NF2 gene product
34. Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system
35. Universal absence of merlin, but not other ERM family members, in schwannomas
36. Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2
37. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members
38. A novel member of the NF2/ERM/4.1 superfamily with growth suppressor properties in lung cancer
39. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
40. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons
41. The neurofibromatosis type 2 gene is inactivated in schwannomas
42. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas
43. Merlin differentially associates with the microtubule and actin cytoskeleton